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Abstract
Background
While the rising pandemic of obesity has received significant attention in many
countries, the effect of this attention on trends and the disease burden of obesity
remains uncertain.
Methods
We analyzed data from 67.8 million individuals to assess the trends in obesity and
overweight prevalence among children and adults between 1980 and 2015. Using
the Global Burden of Disease study data and methods, we also quantified the
burden of disease related to high body mass index (BMI), by age, sex, cause, and
BMI level in 195 countries between 1990 and 2015.
Results
In 2015, obesity affected 107.7 million (98.7-118.4) children and 603.7 million
(588.2- 619.8) adults worldwide. Obesity prevalence has doubled since 1980 in
more than 70 countries and continuously increased in most other countries.
Although the prevalence of obesity among children has been lower than adults,
the rate of increase in childhood obesity in many countries was greater than the
rate of increase in adult obesity. High BMI accounted for 4.0 million (2.7- 5.3)
deaths globally, nearly 40% of which occurred among non-obese. More than two-
thirds of deaths related to high BMI were due to cardiovascular disease. The

9/3/2019 Health Effects of Overweight and Obesity in 195 Countries over 25 Years.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477817/?report=printable 2/38
disease burden of high BMI has increased since 1990; however, the rate of this
increase has been attenuated due to decreases in underlying cardiovascular disease
death rates.
Conclusions
The rapid increase in prevalence and disease burden of elevated BMI highlights
the need for continued focus on surveillance of BMI and identification,
implementation, and evaluation of evidence-based interventions to address this
problem.
Background
The prevalence of overweight and obesity is increasing worldwide, amplifying
concerns over the health risks associated with this worsening problem.
Epidemiological studies have identified high body mass index (BMI) as a risk
factor for an expanding set of chronic diseases including cardiovascular
disease,  diabetes mellitus, chronic kidney disease,  many cancers,  and an
array of musculoskeletal disorders.  As the global health community works to
develop treatments and prevention policies to address obesity, timely information
about levels of high BMI and health impacts at the population level is needed.
In recent years, increasing efforts have been made to assess the trends of BMI
within and across nations.  Other studies have quantified the potential effects of
high BMI on a variety of health outcomes.  These efforts, while useful, have
not considered the relationship of high BMI with broader socio-economic
development; excluded many data sources; focused exclusively on adults;
inadequately captured the skewed distribution of BMI; have not captured
emerging evidence on additional outcomes; and have not assessed the effect of
epidemiologic and demographic transition on disease burden. The optimal level of
BMI for minimum mortality risk has also been questioned.
To address these gaps in knowledge, we systematically evaluated the trends in the
prevalence of overweight and obesity as well as the patterns of deaths and
disability-adjusted life years (DALYs) related to high BMI by age and sex for 195
countries. This analysis supersedes all previous Global Burden of Disease study
(GBD) results for high BMI by comprehensively reanalyzing all data from 1990
through 2015 using consistent methods and definitions.
Methods
We systematically estimated the prevalence of overweight and obesity among
children (<20 years of age) and adults between 1980 and 2015. Using the GBD
comparative risk assessment approach, we also quantified the burden of disease
related to high BMI between 1990 and 2015. The main inputs to our analysis
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included the distribution of BMI by age, sex, country, and year; the effect size of
the change in BMI on disease endpoints; the BMI level associated with the lowest
risk from all causes; and disease-specific mortality and morbidity by country, age,
sex, and year.
Assessment of the Global Distribution of Body Mass Index
We systematically searched Medline for studies providing nationally or sub-
nationally representative estimates of BMI, overweight, or obesity among children
or adults. Studies were included if using standard cutoff points of BMI to define
overweight (BMI: 25-29 kg/m ) and obesity (BMI≥30 kg/m ) among adults or
International Obesity Task Force (IOTF) standard to define overweight and
obesity among children. The search terms, selection criteria, and flow diagrams of
screening are provided in the Appendix. In addition, we searched the Global
Health Data Exchange (http://ghdx.healthdata.org) for multi-country survey
programs, national surveys, and longitudinal studies providing self-report or
measured data on height and weight for children or adults. We identified 1276
unique data sources (855 measured, 421 self-report) from 176 countries providing
data on BMI; 1333 unique sources (802 measured, 531 selfreport) from 176
countries for overweight; and 1514 unique sources (713 measured, 801 self-
report) from 174 countries for obesity among adults. We also identified 1211
unique sources (800 measured, 411 self-report) from 173 countries for BMI, 1236
unique sources (832 measured, 404 self-report) from 174 countries for
overweight, and 1437 unique sources (928 measured, 509 self-report) from 175
countries for obesity among children. Using mixed effects linear regression
models, we separately estimated and corrected for self-report bias among men and
women in each GBD region and age group (Appendix). We characterized the age
and sex patterns for BMI, overweight, and obesity and applied these patterns to
split aggregated report data into five-year age groups by sex (Appendix).
We used spatiotemporal Gaussian process regression (ST-GPR) to estimate the
mean prevalence of overweight and obesity.  To improve our estimates in data-
sparse countries, we tested a wide range of covariates with plausible relationships
to obesity and overweight. We selected three country-level covariates with best fit
and coefficients in the expected direction – as used in other studies.  These
included 10-year lag distributed energy intake per capita, the absolute latitude of
the country, and the proportion of people living in urban areas. To estimate mean
BMI, we first used a mixed effects linear regression to characterize the
relationship between BMI, overweight, and obesity in sources containing
information on all three measures. We applied the coefficients of this regression to
the prevalence of overweight and of obesity generated through ST-GPR to
estimate the mean BMI for each country, age, sex, and year. Of 195 countries and
territories included in the present study, only 8 had no data for any age or sex
group: Antigua and Barbuda, Bermuda, Brunei, Northern Mariana Islands, Saint
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Vincent and the Grenadines, The Bahamas, Turkmenistan, and Venezuela. The
estimates in these countries were constructed purely from the covariates used in
estimation of the linear model and the weighted and smoothed residuals from data
of neighboring countries.
We used a novel method to characterize the distribution of BMI at the population
level. Prior studies have shown that the distribution of BMI becomes skewed as
the mean BMI increases, indicating the need for a flexible distribution that
captures both symmetric and asymmetric patterns of BMI.  To identify the
appropriate distribution, we examined how various distributions (i.e., lognormal,
gamma, inverse Gaussian and beta) approximated the distribution of actual data
from national surveys in six countries; the best fit was provided by the beta
distribution.  To compute the parameters of a beta distribution for BMI, we used
mean BMI, overweight prevalence, and obesity prevalence in each country, age,
sex, and year. Details of this approach have been described elsewhere.
Effect of High Body Mass Index on Health Outcomes
We used Bradford Hill's criteria for causation and the World Cancer Research
Fund evidence grading criteria to systematically evaluate epidemiologic evidence
supporting the causal relationship between high BMI and various disease
endpoints among adults (>25 years of age).  We found convincing or probable
evidence for 20 health outcomes including ischemic heart disease, ischemic
stroke, hemorrhagic stroke, hypertensive heart disease, diabetes mellitus, chronic
kidney disease, esophageal cancer, colon and rectum cancer, liver cancer,
gallbladder and biliary tract cancer, pancreatic cancer, breast cancer, uterine
cancer, ovarian cancer, kidney cancer, thyroid cancer, leukemia, knee
osteoarthritis, hip osteoarthritis, and low back pain (Table S1). For each outcome,
we obtained the relative risk from a dose-response meta-analysis of prospective
observational studies (Table S2). In the case of ischemic heart disease, ischemic
stroke, hemorrhagic stroke, hypertensive heart disease, and diabetes mellitus, we
estimated the relative risk for change in five units of BMI in five-year age groups
from pooled analyses of prospective cohort studies. For breast cancer, we
calculated GBD region-specific relative risk for pre-menopausal and
postmenopausal women because of evidence that overweight and obesity has a
protective effect for breast cancer in premenopausal women in all countries except
for the Asia-Pacific regions (High income Asia Pacific, East Asia, South East
Asia and Oceania)  while a positive association between high BMI and
postmenopausal breast cancer has been observed worldwide.
Optimal Level of Body Mass Index
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Global level
We determined the level of BMI associated with the lowest overall level of risk
based on the findings of the most recent pooled analysis of prospective
observational studies.  To address the limitations of previous publications on this
topic, including residual confounding among smokers and reverse causation due
to pre-existing chronic diseases,  the analysis was restricted to never-smokers
without chronic diseases who survived five years after recruitment. The lowest
rate of all-cause mortality was observed for a BMI level of 20-25 kg/m
Statistical Analysis
To quantify the burden of disease related to high BMI for each endpoint, we
calculated the population attributable fraction (PAF) by country, age, sex, and year
(Appendix). We computed deaths and DALYs related to high BMI for each
country, age, sex, year, and cause by multiplying the PAF by the total deaths or
DALYs estimated in GBD 2015 for that country, age, sex, year, and cause. The
total disease burden of high BMI was calculated as the sum of disease-specific
burden. To understand where in the distribution of BMI most burden occurs, we
estimated PAFs for different levels of BMI (20-24 kg/m ; 25-29 kg/m ; and ≥ 30
kg/m ) and different groups of disease endpoints (cardiovascular disease, diabetes
mellitus, chronic kidney disease, neoplasms, and musculoskeletal disorders).
We decomposed the change in death and DALY rates attributed to high BMI
between population growth, population age structure, risk exposure to high BMI,
and risk-deleted death and DALY rates using methods developed by Das Gupta .
Risk-deleted rates are the burden of disease in the absence of the risk factor.
We computed 95% uncertainty intervals for all results using Monte Carlo
simulations, keeping 1000 draws of each quantity of interest to propagate
uncertainty into final estimates. The model included uncertainty from examination
surveys; the relative risks for each outcome from the pooled analysis or meta-
analysis of cohorts; the optimal level of BMI; and the deaths and DALYs
estimated for each country, age, sex, year, and outcome from GBD 2015.
Following methods outlined in the GBD 2015 study, we used a Socio-
demographic Index (SDI) – a summary measure of lag-distributed income per
capita, average educational attainment over the age of 15 years, and total fertility
rate – to position countries on the development continuum .  A list of countries
with their SDI level in 2015 is provided in Table S3.
Results
Prevalence of obesity (1980-2015)
In 2015, 107.7 million (98.7-118.4 million) children and 603.7
million (588.2-619.8 million) adults were obese worldwide. The overall
prevalence of obesity for children and adults was 5.0% and 12.0% respectively.
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By level of Socio-demographic Index
National level
Among adults, the prevalence of obesity was generally higher for women than for
men in all age brackets (Figure 1). The peak in prevalence of obesity was
observed at age 60 to 64 for women and at age 50 to 54 for men. Rates of increase
between 1980 and 2015 were not significantly different between women and men
in any age bracket; for both, rates of increase were highest in early adulthood.
Among children, the prevalence of obesity in 2015 decreased with age bracket
until age 14 and then increased; no sex differences were observed in obesity
prevalence before age 20. Between 1980 and 2015, rates of increase in global
childhood obesity were equal for boys and girls in all age brackets.
At all levels of SDI and for all age groups,
the prevalence of obesity was generally higher for women than for men in 2015 (
Figure 1); the prevalence of obesity in adults was highest for women aged 60 to
64 in high SDI countries. In general, the prevalence of obesity for both women
and men increased with SDI across all age groups. An exception was the
prevalence of obesity in women in low SDI geographies—after age 55 to 59,
prevalence was higher for women in low SDI geographies than for women of
equivalent age in low-middle SDI (Figure 1). Obesity prevalence increased fastest
over the period 1980 to 2015 for men age 25 to 29 in lowmiddle SDI countries,
from 11.1% (8.5-14.7%) in 1980 to 38.3% (30.7-48.1%) in 2015. Obesity
prevalence increased by 2.4 fold in both men and women of all ages in low-
middle and middle SDI countries between 1980 and 2015.
Overall, prevalence of obesity for children was greater at higher SDI (Figure 1).
At most levels of SDI, prevalence of obesity for children was lowest for both boys
and girls between ages 10 to 14. In high and high middle SDI geographies alone,
prevalence was generally greater for boys than girls, although this difference
reversed beginning with late adolescence (Figure 1). A significant increase was
observed in the prevalence of obesity between 1980 and 2015 at low SDI for both
girls and boys 20.0% (5.5-35.3%). The highest rates of increase between 1980 and
2015 were observed in middle SDI geographies for both girls and boys.
The estimated age-standardized prevalence of obesity and
overweight among children and adults for all 195 countries and territories are
provided in the Table S3 here we highlight the findings related to obesity in the
most populous countries (Figure 2). Amongst the 20 most populous countries, the
highest level of adult obesity in 2015 was observed in Egypt at 34.9% (32.4-
37.3%) and the highest level of childhood obesity was in United States at 12.7%
(12.0-13.4%); prevalence was lowest for adults in Vietnam at 1.6% (1.3-2.1%)
and for children in Bangladesh at 1.2% (0.8-1.9%). The prevalence of obesity
doubled or increased more than 2- fold in 13 of these countries between 1980 and
2015; only the Democratic Republic of the Congo showed no increase (Figure S1
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Global level
By level of Socio-demographic Index
and Figure S2). China and India had the highest number of obese children while
the United States and the Philippines had the highest number of obese adults in
2015.
Burden of disease related to high BMI (1990-2015)
In 2015, excess weight contributed to 4.0 million (2.7-5.3 million)
deaths (7.2% [4.9-9.4%] of allcause deaths) and 120 million (84-158 million)
DALYs (4.9% [3.5-6.4%] of all-cause DALYs) among adults globally. Nearly
39% of deaths and 36% of DALYs related to high BMI occurred in those with a
BMI <30 kg/m2 ( ). Cardiovascular disease was the leading cause of deaths
and DALYs related to high BMI, accounting for 2.7 million (1.8-3.7 million)
deaths and 66.3 million (45.3-88.5 million) DALYs (Table S4). Globally, 41% of
BMI-related deaths and 34% of BMI-related DALYs were due to cardiovascular
disease among obese people (BMI>30 kg/m2). Diabetes was the second leading
cause of BMI-related deaths in 2015, contributing to 0.9 million (0.6-1.1 million)
deaths and 39.1 million (28.1-51.1 million) DALYs; 9.5% and 4.5% of all BMI-
related deaths were due to diabetes at BMI >30 and <30 respectively. Chronic
kidney disease was the second leading cause of BMI-related DALYs in 2015;
18.0% of DALYs occurred at BMI >30 and 7.3% at BMI <30. Chronic kidney
disease and neoplasms each accounted for less than 10% of all BMI-related deaths
in 2015, while neoplasms, diabetes, and musculoskeletal disorders each
contributed less than 10% of BMI-related DALYs (Figure 3). High BMI also
accounted for 28.6 million (17.8-41.4 million) years lived with disability (YLD)
(3.6% [2.7-4.6%] of all-cause YLDs) globally. Diabetes was the leading cause of
YLDs related to BMI (19.3 million [12.2-27.4 million]) followed by
musculoskeletal disorders (5.7 million [3.4-8.8 million]) and cardiovascular
disease (3.3 million [2.0-4.9 million]).
The global mortality related to high BMI increased by 28.3% from 41.9 per
100,000 in 1990 to 53.7 per 100,000 in 2015, although age-standardized mortality
rates did not significantly change in this period (64.0 [41.7-89.7] per 100,000 in
1990 and 60.2 [43.1-81.5]) per 100,000 in 2015). Similarly, BMI-related DALYs
increased by 35.8% between 1990 and 2015, from 1200 per 100,000 to 1630 per
100,000 while no significant change was observed in age-standardized rates.
 illustrates that, globally, percent change in BMI-related deaths and DALYs
due to risk-deleted mortality rates were matched by increases from other factors.
Of the disease endpoints considered in this study, decreases in the risk-deleted
mortality rate for cardiovascular disease contributed the most to this pattern.
Change due to risk exposure and population aging were roughly equal in terms of
their contribution to both percent change of related deaths and DALYs globally
between from 1990 to 2015.
Figure 3
Figure 4
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National level
Age-standardized rates of both BMI-related deaths and DALYs were greatest in
high-middle SDI (deaths, 60.1 [47.1-91.6] and DALYs, 1890 [1330-2460] per
100,000) and lowest at high SDI (deaths, 52.6 [38.73-67.9] and DALYs 1530
[1160-1920] per 100,000) in 2015. The all-ages rate of BMI-related deaths
increased between 1990 and 2015 at all SDI levels, with a peak for high SDI in
the year 2005 at 2359 (1749-2997) per 100,000. Age-standardized rates of death
at high and high-middle SDI decreased between 1990 and 2015; in the lowest
quintiles, agestandardized BMI-related deaths increased. With increasing levels of
SDI, the contribution of risk-deleted mortality rate to the percent change in all-
cause related deaths increased while the contribution of population growth to
percent change in mortality decreased ( ). The contribution of risk exposure
to percent change in BMI-related deaths was also generally inversely related to
SDI. Patterns in the decomposition of sources of change for BMI-related DALYs
were parallel to those observed for mortality. In disease-specific decomposition,
riskdeleted mortality and DALY rates showed a declining trend for most causes
across all levels of SDI (Table S5). The largest decrease in risk-deleted deaths and
DALYs were observed for cardiovascular disease while cancers and
musculoskeletal disorders showed the least decline respectively.
Among the 20 most populous countries, the highest burden of
related deaths and DALYs was observed in Russia; the lowest rate of related
deaths and DALYs occurred in the Democratic Republic of the Congo (Figure
S3). Between 1990 and 2015, the greatest percent change in related deaths and
DALYs occurred in Russia at 42.2% (31.9-55.9%) and 26.6% (19.6-36.1%)
respectively while rates of change were lowest in Japan (deaths, 20.5% [12.7-
28.2%]; DALYs, 1.0% [-3.8-5.6%]) (Table S6).
Discussion
Our systematic evaluation demonstrates that excess body weight is a major risk
factor for mortality and morbidity, accounting for 4.0 million deaths and 120
million DALYs worldwide. Nearly 70 percent of deaths related to high BMI are
due to cardiovascular disease and over 60 percent of those deaths occurs among
the obese. The prevalence of obesity has increased over the past three decades,
and at a faster pace than the related burden. Both the trend and magnitude of the
BMI-related disease burden, however, vary widely across countries and at
different levels of socio-demographic status.
Among leading risks for health assessed in the GBD 2015, high BMI continues to
have one of the highest rates of increase. Across levels of development, the
prevalence of obesity has increased over recent decades indicating the problem is
not simply a function of income or wealth.  Changes in the food environment
and food systems are likely to be major drivers.  Increased availability,
accessibility, and affordability of energy-dense foods, along with intense
Figure 4
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marketing of such foods could sufficiently explain excess energy intake and
weight gain in different populations.  The reduced opportunities for physical
activity that have followed urbanization and other changes in the built
environment have also been considered as potential drivers; however, these
changes generally preceded the global increase in obesity and are less likely to be
major contributors.
Over the past decade, a range of interventions in the food environment and the
food system have been proposed in order to reduce obesity.  These include
restricting the advertisement of unhealthy foods to children, improving school
meals, using taxation to reduce consumption of unhealthy foods and subsidies to
increase intake of healthy foods, and using supply-chain incentives to increase
production of healthy foods.  However, the effectiveness, feasibility of
widespread implementation, and sustainability of these interventions need to be
evaluated in various settings. In recent years, some countries have started to
implement some of these policies  but no major population success has yet been
demonstrated. Many of the countries that have experienced the highest increase in
the prevalence of obesity are low or middle SDI countries that simultaneously
suffer from high rates of other forms of malnutrition, creating additional
challenges. These countries generally have limited financial resources for
nutrition programs and mostly rely on external donors whose programs often
preferentially target undernutrition; consequently, food security frequently takes
precedence over obesity in these countries. In a review of the nutrition policies in
countries with a double burden of undernutrition and obesity, only one country
reported funding partners available to address both aspects of malnutrition.  In
2013, the World Health Organization (WHO) called for zero increase in the
prevalence of obesity among adults and zero increase in the prevalence of
overweight among children.  However, given the current pace of increase and
the existing challenges in implementing food policies, achieving this goal appears
unlikely in the near future. While policy interventions targeting behavioral
change, the food environment, and food systems might be successful in
prevention of further weight gain or even achieving modest weight loss over the
long term, limited improvement can be expected at the individual level in the
short term. Given the rising burden of obesity and extreme obesity, health care
professionals need to play a more active role in both the promotion of weight loss
and controlling the complications of obesity.  Training for health care
professionals on evidencebased options for treatment of obese adults and children
(e.g., behavioral change techniques, medications, and bariatric surgery) is
necessary – although limited options are available for treatment of childhood
obesity. Such treatment needs to be selected based on the intensity of obesity and
their cost-effectives and will only be sustained if accompanied by supporting
policies targeting the food environment and food system.
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Our study found a greater rate of increase in exposure to high BMI than for the
related disease burden. This difference is mainly driven by the decline in risk-
deleted mortality rates, particularly for cardiovascular disease; factors such as
improved treatment or changes in other risks have resulted in cardiovascular
disease declines despite increases in BMI. This observation has important
implications for attempts to reduce the disease burden of high BMI at the
population level. Existing evidence-based policies, even if fully implemented, are
unlikely to rapidly reduce the prevalence of obesity. Clinical interventions,
however, have proved effective in controlling high systolic blood pressure,
cholesterol, and high fasting plasma glucose (the major risk factors for
cardiovascular disease) and are thus implicated in the decrease in underlying
disease burden.  Expanded use of such interventions among obese people could
effectively reduce the disease burden of high BMI. This approach will also
mitigate the effect of high BMI on cardiovascular disease by removing the effect
of BMI mediated through these risk factors. A recent pooled cohort analysis
including 1.8 million participants found that nearly half of excess risk for
ischemic heart disease related to high BMI and more than 75% of the excess risk
for stroke was mediated through the combination of raised blood pressure, total
serum cholesterol and fasting plasma glucose.  Together, these findings suggest
that clinical interventions to reduce the underlying rate of cardiovascular disease
could substantively reduce the burden of disease related to high BMI, although
maintaining a normal body weight remains necessary to achieve full benefit.
Globally, 40% of deaths and 38% of the DALYs related to high BMI occurred
among non-obese individuals. While some studies have argued that overweight is
associated with lower risk of allcause mortality compared to a normal range of 18-
25 kg/m ,  recent evidence from metaanalysis16 and pooled analysis11 of
prospective observational studies found a continuous increase in the risk of death
for BMI above 25 kg/m . These recent publications are particularly notable
because they addressed major sources of bias in prior studies (i.e. residual
confounding by smoking and reverse causation due to pre-existing chronic
disease) by restricting the analysis to never smokers without chronic diseases.
Additionally, the pooled cohort analysis controlled for the same set of covariates,
provided cause-specific relative risks, and evaluated the relationship between
BMI and mortality across different regions. The balance of evidence thus supports
our minimum risk level BMI of 20-25 kg/m . Given this, our study suggests that
nonobese individuals carry a large proportion of the total burden that would be
missed by focusing solely on the obese individuals. At the same time, to date,
there remains insufficient evidence to support the argument that the optimal level
of BMI should vary geographically or by ethnicity  because of differences in the
relationship between BMI and body fat distribution. We found that 4% of the
DALYs related to high BMI were from musculoskeletal disorders. Although high
BMI is a major risk factor contributing to years lived with disability globally, and
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the economic costs associated with treatment are substantial,  these non-fatal but
debilitating health outcomes have received comparatively little policy attention.
Similar to cardiovascular outcomes, weight loss is beneficial in prevention and
treatment of musculoskeletal pain. In the Framingham Study, a decrease in BMI
of 2 or more units in the decade prior to evaluation was found to decrease the
odds of developing knee osteoarthritis by more than 50%.  A combination of
modest weight loss and moderate exercise provides better overall improvement in
musculoskeletal pain than either intervention alone;  however, surgical
interventions may be most effective for the morbidly obese.
Our systematic evaluation of prospective observational studies found sufficient
evidence supporting a causal relationship between high BMI and cancers of the
esophagus, colon and rectum, liver, gallbladder and biliary tract, pancreas, breast,
uterus, ovary, kidney, thyroid, and leukemia. A recent review by the International
Agency for Research on Cancer (IARC) comes to largely similar conclusions, but
with some notable differences.  For example, although the IARC report did not
include leukemia, we included this outcome based on a systematic review and
meta-analysis of 21 prospective cohort studies30 which found a significant
association between obesity (BMI>30) and incidence and mortality from
leukemia. Additionally, while the IARC report acknowledged consistent inverse
associations between BMI and the risk of premenopausal breast cancer,
inconsistent findings from studies evaluating the effect of waist circumference or
body-weight gain resulted in its exclusion. However, since high BMI was the
exposure of interest in our analysis, we included the protective effect of high BMI
on breast cancer in pre-menopausal women. We did not evaluate the effect of high
BMI on gastric cancer (cardia) and meningioma due to lack of sufficient data to
separately estimate the incidence and mortality of these cancers at the population
level.
Our study has several important strengths. We have addressed the major
limitations of prior studies by including more data sources and quantifying the
prevalence of obesity among children. We also systematically evaluated the
strength of evidence for the causal relationship between high BMI and health
outcomes and included all BMI-outcome pairs for which sufficient evidence on
causal relationship was available. We used a beta distribution to characterize the
distribution of BMI at the population level, which captures the fraction of the
population with high BMI more accurately than other distributions.  We used the
best available evidence to determine the optimal level of BMI. We quantified the
trends and disease burden of high BMI across levels of development and
estimated the contribution of demographic transition and epidemiologic transition
to changes in BMI-related burden.
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Potential limitations that may result in over- or underestimation of the prevalence
of obesity or disease burden from high BMI should also be considered. We used
both self-report and measured height and weight data and corrected the self-
reported data based on measured data at each age, sex, and country unit. To apply
a consistent definition for childhood overweight and obesity across sources, we
used the International Obesity Task Force definition and excluded studies using
the World Health Organization definition. We did not propagate the uncertainty in
the age pattern and sex pattern used to split the data as they seemed to have small
effect. We did not incorporate the uncertainty of the regression coefficients in our
analysis. Early data were particularly sparse for many locations and estimates
were based on country level covariates and regional data. We did not identify a
consistent pattern in the relationship of nationally representative data with data
representing only urban or rural areas across geographies and were not able to
correct those data for potential bias. We did not evaluate the trend and disease
burden of other measures of adiposity that may better relate to specific health
outcomes including waist circumference or waist to hip ratio. We identified few
data points for some countries and the trends in these countries are mostly driven
by the covariates included the models. We did not evaluate the health losses due
to low BMI in this study and our results might be a conservative estimate of the
overall disease burden of suboptimal BMI. We obtained the effect size of BMI on
health outcomes from prospective observational studies and the possibility of
confounding by lifestyle habits cannot be excluded. Our estimation of relative
risks did not capture possible differences due to ethnicity and did not account for
the possibility of geographic variation for relative risk curves or optimal level for
BMI. The relative risks of BMI on disease endpoints are mostly obtained from
meta-analyses or pooled analyses of prospective observational studies. These
studies, generally excluded people with prevalent chronic diseases from the
analysis of relative risk estimation. Thus, our estimates represent the effect of
BMI in people without underlying diseases. This issue might be particularly
important for older age groups were the prevalence of chronic disease increases.
Finally, other probable complications or forms of BMI-related burden (e.g.,
disease burden in children) were not included.
In summary, our study provides one of the most comprehensive assessments of
the trends and disease burden of high BMI to date. Our results show that both the
rate and the disease burden of high BMI is increasing globally. This highlights the
need for implementation of multicomponent interventions to reduce the
prevalence and disease burden of high BMI.
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Global prevalence of obesity in 2015 by age, sex, and quintile of Socio−demographic Index
(a) and trends in age−standardized prevalence of obesity among children (b) adults (c).
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Figure 2
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Age−standardized national prevalence of obesity among adult (males [a], females [b]) and
children (males [c], females [d]) in 2015.
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Figure 3
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Global disability-adjusted life years (in millions) related to high body mass index (BMI)
among adults by cause and the level of BMI in 1990 (a) and 2015 (b) and global deaths (in
millions) related to high BMI in 1990 (c) and 2015 (d).
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Figure 4
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Decomposition of percent changes in all−cause disability-adjusted life years (DALYs) (a) and
deaths(b) related to high body mass index from 1990 to 2015 due to population growth,
population ageing, risk exposure and the underlying rates of DALYs and deaths by quintiles
of Socio−demographic Index. Locations are reported in order of percent change in the
number of related DALYs from 1990 to 2015. DALYs=disability−adjusted life−years.
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